HiScreen Capto L, 1 × 4.7 mL
Suitable for the capture of a wide range of antibody fragments such as Fabs, dAbs, and singlechain fragment variable (scFv) .
High binding capacity, low ligand leakage, and selectivity for a broad range of antibody fragments reduces process time and amount of resin.
Enables a platform approach to antibody fragment purification.
Excellent productivity, process economy, and process design flexibility due to rigid matrix.
Hydrophilic base matrix ensures low levels of nonspecific binding and low levels of host cellderived impurities in the elution pool.
Fulfills industrial demands for security of supply, robust performance, and regulatory support.